[
  {
    "info": {
      "NCT": "NCT05052801",
      "Protocol_No": "AMG 552-20210096 (FORTITUDE-101)",
      "jit": "Avera Trials",
      "trial_name": "AMG 552 (FORTITUDE-101)"
    },
    "disease": {
      "summary": "Gastric Cancer, Gastroesophageal Junction Adenocarcinoma",
      "details": [
        {
          "code": "Adenocarcinoma of the Gastroesophageal Junction (GEJ)",
          "selection": "include",
          "stage": "Advanced Stage;Metastatic"
        }
      ]
    },
    "query": {
      "nct": "NCT05052801",
      "title": "Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression",
      "current_status": "Recruiting",
      "status_verif_date": "May 2023",
      "last_update_date": "May 10, 2023",
      "trial_hold_status": "open",
      "sponsor": "Amgen",
      "brief_summary": "The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6) to placebo plus mFOLFOX6 as assessed by overall survival (OS) in participants with FGFR2b ≥10% 2+/3+ tumor cell staining (FGFR2b ≥10% 2+/3+TC)",
      "conditions": "Gastric Cancer | Gastroesophageal Junction Adenocarcinoma",
      "type": "Interventional",
      "phase": "Phase 3",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Bemarituzumab with mFOLFOX6",
          "drug": "Bemarituzumab | mFOLFOX6",
          "arm_type": "Experimental",
          "line_of_therapy": "1",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Bemarituzumab with mFOLFOX6",
              "Gene": "FGFR2",
              "Gene2": "Not available",
              "Type": "Not available",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Overexpression",
              "summary": "FGFR2 Overexpression"
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Placebo with mFOLFOX6",
          "drug": "mFOLFOX6 | Placebo",
          "arm_type": "Active Comparator",
          "biomarker": [
            {
           "cohort": "Placebo with mFOLFOX6",
               "Gene": "Not available",
               "Gene2": "Not available",
               "Type": "Not available",
               "Variant": "Not available",
               "Selection": "include",
               "Function": "Not available",
               "summary": "absent"
	     }
          ]
        }
      ],
      "docs": "<a href=\"https://avera-ereg-prod.forteresearchapps.com/ereg-web/protocols/1783/section-3918\" target=\"_blank\">eREG<\/a>",
      "doclastupdate": "2023-05-11",
      "locations": "Sioux Falls SD",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT05052801\" target=\"_blank\">NCT05052801<\/a>"
    }
  }
]
